Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor

Journal of Clinical Neuroscience

Volumn 15, Issue 11, 2008, Pages 1198-1203

  Kogiku, Minoru ^a,b   Ohsawa, Ikuroh ^a   Matsumoto, Koushi ^b   Sugisaki, Yuichi ^b   Takahashi, Hiroshi ^b   Teramoto, Akira ^b   Ohta, Shigeo ^a  

^a Graduate School of Medicine   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

EGFR index; Glioma; Immunohistochemical staining; Prognosis; Survivin index

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; SURVIVIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 53349166957     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.11.012     Document Type: Article

References (29)

1. Louis D.N., Pomeroy S.L., and Cairncross J.G. Focus on central nervous system neoplasia. Cancer Cell 1 (2002) 125-128
2. The Committee of Brain Tumor Registry of Japan. Report of brain tumor registry of Japan (1969-1996). Neurol Med Chir (Tokyo) 2003;Suppl:36-44.
3. Kallio M., Sankila R., Jaaskelainen J., et al. A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 68 (1991) 1394-1400
4. Surawicz T.S., Davis F., Freels S., et al. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40 (1998) 151-160
5. Noble M., and Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci 27 (2004) 148-154
6. McKeever P.E. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem 46 (1998) 585-594
7. Uematzu M., Ohsawa I., Aokage, et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 72 (2005) 231-238
8. Chakravarti A., Noll E., Black P.M., et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20 (2002) 1063-1068
9. Kajiwara Y., Yamasaki F., Hama S., et al. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97 (2003) 1077-1083
10. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22 (2003) 8581-8589
11. Caldas H., Jiang Y., Holloway M.P., et al. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24 (2005) 1994-2007
12. Freije W.A., Castro-Vargas F.E., Fang Z., et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64 (2004) 6503-6510
13. Mischel P.S., Cloughesy T.F., and Nelson S.F. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 5 (2004) 782-792
14. Libermann T.A., Razon N., Bartal A.D., et al. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44 (1984) 753-760
15. Simmons M.L., Lamborn K.R., Takahashi M., et al. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61 (2001) 1122-1128
16. Shinojima N., Tada K., Shiraishi S., et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 63 (2003) 6962-6970
17. Kaplan E.L., and Meier P. Non-parametric estimates from incomplete observations. J Am Anat Assoc 53 (1953) 457-480
18. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
19. Xie D., Zeng Y.X., Wang H.J., et al. Expression of cytoplasmic and nuclear survivin in primary and secondary human glioblastoma. Br J Cancer 94 (2006) 108-114
20. Kobayashi K., Hatano M., Otaki M., et al. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 96 (1999) 1457-1462
21. Skoufias D.A., Mollinari C., Lacroix F.B., et al. Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151 (2000) 1575-1582
22. Li F., Ackermann E.J., Bennett C.F., et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1 (1999) 461-466
23. Wong A.J., Bigner S.H., Bigner D.D., et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84 (1987) 6899-6903
24. Lund-Johansen M., Bjerkvig R., Humphrey P.A., et al. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50 (1990) 6039-6044
25. Jaros E., Perry R.H., Adam L., et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 66 (1992) 373-385
26. Korkolopoulou P., Christodoulou P., Kouzelis K., et al. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 75 (1997) 1269-1278
27. Etienne M.C., Formento J.L., Lebrun-Frenay C., et al. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin Cancer Res 4 (1998) 2383-2390
28. Bouvier-Labit C., Chinot O., Ochi C., et al. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol 24 (1998) 381-388
29. Sanson M., Thillet J., and Hoang-Xuan K. Molecular changes in gliomas. Curr Opin Oncol 16 (2004) 607-613